Inhibrx Biosciences Inc. monthly returns
Inhibrx Biosciences Inc. has averaged 5.01% per month, positive in 51% of months. Month-by-month returns for Inhibrx Biosciences Inc. (INBX) below, through October 20, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Inhibrx Biosciences Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -4.8% | |
| Sep 2026 | -21.0% | |
| Aug 2026 | +54.4% | |
| Jul 2026 | -13.4% | |
| Jun 2026 | -8.9% | |
| May 2026 | -19.5% | |
| Apr 2026 | +92.2% | |
| Mar 2026 | -9.3% | |
| Feb 2026 | -2.8% | |
| Jan 2026 | -3.5% | |
| Dec 2025 | -6.1% | |
| Nov 2025 | +3.0% | |
| Oct 2025 | +142.5% | |
| Sep 2025 | +19.4% | |
| Aug 2025 | +28.6% | |
| Jul 2025 | +53.6% | |
| Jun 2025 | +5.9% | |
| May 2025 | +9.2% | |
| Apr 2025 | -11.9% | |
| Mar 2025 | +5.6% | |
| Feb 2025 | -2.4% | |
| Jan 2025 | -11.8% | |
| Dec 2024 | +0.9% | |
| Nov 2024 | -4.8% | |
| Oct 2024 | +2.4% | |
| Sep 2024 | +7.6% | |
| Aug 2024 | +0.3% | |
| Jul 2024 | +2.4% | |
| Jun 2024 | -12.8% | |
| May 2024 | -52.3% | |
| Apr 2024 | -2.6% | |
| Mar 2024 | -4.6% | |
| Feb 2024 | -4.9% | |
| Jan 2024 | +1.4% | |
| Dec 2023 | +83.0% | |
| Nov 2023 | +34.3% | |
| Oct 2023 | -15.7% | |
| Sep 2023 | -14.3% | |
| Aug 2023 | +6.7% | |
| Jul 2023 | -22.8% | |
| Jun 2023 | +9.7% | |
| May 2023 | +12.7% | |
| Apr 2023 | +11.3% | |
| Mar 2023 | -21.6% | |
| Feb 2023 | -3.8% | |
| Jan 2023 | +1.5% | |
| Dec 2022 | -17.8% | |
| Nov 2022 | -6.8% | |
| Oct 2022 | +79.3% | |
| Sep 2022 | +1.2% | |
| Aug 2022 | +2.3% | |
| Jul 2022 | +52.8% | |
| Jun 2022 | -13.2% | |
| May 2022 | -17.5% | |
| Apr 2022 | -28.9% | |
| Mar 2022 | +3.6% | |
| Feb 2022 | -19.1% | |
| Jan 2022 | -39.2% | |
| Dec 2021 | +8.0% | |
| Nov 2021 | +0.6% | |
| Oct 2021 | +20.7% | |
| Sep 2021 | +16.8% | |
| Aug 2021 | +0.2% | |
| Jul 2021 | +3.4% | |
| Jun 2021 | +30.1% | |
| May 2021 | -0.8% | |
| Apr 2021 | +6.3% | |
| Mar 2021 | -21.0% | |
| Feb 2021 | -19.8% | |
| Jan 2021 | -3.9% | |
| Dec 2020 | +19.8% | |
| Nov 2020 | +61.5% | |
| Oct 2020 | -5.3% | |
| Sep 2020 | +2.9% |
Monthly total return (since Nov 2021)#
Inhibrx Biosciences Inc. returns by calendar month#
Every month of every year since 2021, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -4.78% — 5th of 6 Octobers since 2021 at the last close; the average October returned +45.8%.
| Month | −145%0+145% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | -9.2% | -3.7% | 33% | +1.5% 2023 | -39.2% 2022 | |
| Feb | -8.8% | -4.3% | 0% | -2.4% 2025 | -19.8% 2021 | |
| Mar | -7.9% | -6.9% | 33% | +5.6% 2025 | -21.6% 2023 | |
| Apr | +11.1% | +1.8% | 50% | +92.2% 2026 | -28.9% 2022 | |
| May | -11.4% | -9.2% | 33% | +12.7% 2023 | -52.3% 2024 | |
| Jun | +1.8% | -1.5% | 50% | +30.1% 2021 | -13.2% 2022 | |
| Jul | +12.7% | +2.9% | 67% | +53.6% 2025 | -22.8% 2023 | |
| Aug | +15.4% | +4.5% | 100% | +54.4% 2026 | +0.2% 2021 | |
| Sep | +1.6% | +4.4% | 67% | +19.4% 2025 | -21.0% 2026 | |
| Oct | +45.8% | +20.7% | 80% | +142.5% 2025 | -15.7% 2023 | |
| Nov | +5.2% | +0.6% | 60% | +34.3% 2023 | -6.8% 2022 | |
| Dec | +13.6% | +0.9% | 60% | +83.0% 2023 | -17.8% 2022 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from INBX's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Inhibrx Biosciences Inc.'s average monthly return?
- Inhibrx Biosciences Inc. (INBX) has averaged about 5.01% per month, positive in roughly 51% of months. The best month was Oct 2025 (+142.5%) and the worst was May 2024 (-52.3%).